Rahul Gupta
Nuclear Cardiology · New Haven, CTNPI 1538681457
Payments from drug & device makers
What this record shows
This record is dominated by grants: $15,000 of the $23,798 with a category attached, or 63.0%. Medtronic accounts for 69.5% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2024 at $19,526 and has fallen 97.1% since, to $570 in 2025.
Across 147 payments — averaging $161.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$17K
- Edwards Lifesciences$2K
- Chiesi USA, Inc.$1K
- Abiomed$1K
- Boston Scientific$992
- GE HealthCare$398
- plus $1K from 15 others
What the payments were for
- Consulting fees$4382%
- Speaking & faculty fees$1,2005%
- Grants$15,00063%
- Travel & lodging$2,49510%
- Food & beverage$4,04017%
- Education$6253%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 76 | $16,537 |
| Edwards Lifesciences | 18 | $2,139 |
| Chiesi USA, Inc. | 2 | $1,272 |
| Abiomed | 12 | $1,204 |
| Boston Scientific | 7 | $992 |
| GE HealthCare | 1 | $398 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $336 |
| Esperion Therapeutics, Inc. | 4 | $282 |
| Cathworks, Inc. | 1 | $168 |
| Pfizer | 6 | $126 |
| Abbott | 2 | $104 |
| Penumbra, Inc. | 1 | $63 |
| Johnson & Johnson | 1 | $29 |
| Boehringer Ingelheim | 1 | $24 |
| Shockwave Medical, Inc | 1 | $22 |
| Stryker | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Eagle Pharmaceuticals, Inc. | 1 | $18 |
| Novartis | 1 | $17 |
| Getinge USA Sales, LLC | 1 | $15 |
| AstraZeneca | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$15,545
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,571
- JUXTAPID$1,200
- Impella$786
- VSCAN$398
- GENERAL - THERAPIES$180
- FFRangio$168
- RESOLUTE ONYX$149
- NEXLIZET$125
- NEXLETOL$125
- INTELLIS ADAPTIVESTIM$110
How this compares
Too few nuclear cardiology providers in Connecticutto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nuclear cardiology in New Haven
- Edward MillerNew Haven$36K
- Sanjeev BhavnaniHartford$29K
- Gary HellerHartford$11K
- William DuvallHartford$10K
- Adam SchussheimFairfield$10K
- Vinay GulatiHartford$8K
- Mehran SadeghiWest Haven$101
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.